Nordihydroguaiaretic acid reverses the antibacterial activity of colistin against MCR-1-positive bacteria in vivo/in vitro by inhibiting MCR-1 activity and injuring the bacterial cell membrane

Ge Song; Yonglin Zhou; Sen Niu; Xuming Deng; Jiazhang Qiu; Li Li; Jianfeng Wang

doi:10.1016/j.phymed.2022.153946

Nordihydroguaiaretic acid reverses the antibacterial activity of colistin against MCR-1-positive bacteria in vivo/in vitro by inhibiting MCR-1 activity and injuring the bacterial cell membrane

Phytomedicine. 2022 Apr:98:153946. doi: 10.1016/j.phymed.2022.153946. Epub 2022 Jan 29.

Authors

Ge Song¹, Yonglin Zhou¹, Sen Niu², Xuming Deng¹, Jiazhang Qiu², Li Li², Jianfeng Wang³

Affiliations

¹ Department of Respiratory Medicine, the First Hospital of Jilin University, Changchun, China; State Key Laboratory for Zoonotic Diseases, College of Veterinary Medicine, Jilin University, Changchun, China.
² State Key Laboratory for Zoonotic Diseases, College of Veterinary Medicine, Jilin University, Changchun, China.
³ Department of Respiratory Medicine, the First Hospital of Jilin University, Changchun, China; State Key Laboratory for Zoonotic Diseases, College of Veterinary Medicine, Jilin University, Changchun, China. Electronic address: wjf927@jlu.edu.cn.

PMID: 35158237
DOI: 10.1016/j.phymed.2022.153946

Abstract

Background: Colistin (polymyxin E) is an effective antibiotic for the treatment of most multidrug-resistant Gram-negative bacteria. However, some bacteria, including bacterial spp. belonging to the Enterobacteriaceae family, have an acquired resistance against polymyxins, which is attributed to they possess plasmid-carried resistance genes (mcr-1 and its variants). So, there is an urgent need to develop new therapeutic strategies to target broad spectrum resistant spp. from Enterobacteriaceae family in response to the loss of the protective barrier of last-line antibiotics. Here, we report the adjuvant capacity of nordihydroguaiaretic acid (NDGA) for restoring the antibacterial activity of colistin against MCR-1-positive E. coli ZJ487 in vivo/in vitro.

Methods: A checkerboard assay, time-killing analysis, isobolograms, growth curves and inducible resistance test showed the effect of NDGA combined with colistin in vitro. TLC was used to detect the inhibitory effect of NDGA on MCR-1. Colony determination and hematoxylin and eosin (HE) staining were used to assess the synergistic effect of NDGA and colistin in mice.

Results: Our results showed that NDGA in combination with colistin showed a synergistic bactericidal action without inducing resistance. NDGA directly inhibited MCR-1 activity and resulted in measurable injury to the bacterial cell membrane to recover the antibacterial effect of colistin. Most importantly, NDGA in combination with colistin exhibited an in vivo synergistic effect in murine peritonitis infection models, as evidenced by the survival rate of MCR-1-positive E. coli ZJ487-infected mice which increased from 6.67 to 50.0%.

Conclusion: Our study demonstrated that NDGA effectively rescues the efficiency of colistin against MCR-positive E. coli ZJ487 by simultaneously inhibiting both, the MCR activity and the injury to the cell membrane of bacteria.

Keywords: Colistin, MCR-1; Nordihydroguaiaretic acid; Synergy.